(Q52942611)

9 May 2018

title

Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates. (English)

1 reference

9 May 2018

1 reference

1

Eric J Feuer

1 reference

9 May 2018

Angela Mariotto

series ordinal

2

object named as

Angela Mariotto

1 reference

9 May 2018

author name string

Ray Merrill

series ordinal

3

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 August 2002

1 reference

9 May 2018

number of pages

11

1 reference

inferred from page(s)

published in

Cancer

1 reference

9 May 2018

volume

95

1 reference

9 May 2018

page(s)

870-880

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

Changing trends in U.S. prostate cancer incidence rates.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

Changes in the use of radical prostatectomy for treating prostate cancer in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

7 January 2021

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

7 January 2021

Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

7 January 2021

The European Randomized Study of Screening for Prostate Cancer (ERSPC): an update. Members of the ERSPC, Section Rotterdam

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10726

7 January 2021

Identifiers

DOI

10.1002/CNCR.10726

1 reference

9 May 2018

PubMed ID

12209732

1 reference

9 May 2018